Cutaneous drug eruptions: A 5-year experience

Journal of the American Academy of Dermatology

Volumn 59, Issue 6, 2008, Pages 995-999

  Gerson, Deborah ^a   Sriganeshan, Vathany ^a   Alexis, John B ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIGOUT AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENOXAPARIN; PHENYTOIN; PROTON PUMP INHIBITOR; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG ERUPTION; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; RASH;

ADULT; AGED; AGED, 80 AND OVER; DRUG ERUPTIONS; EOSINOPHILS; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; RETROSPECTIVE STUDIES; SKIN; SKIN DISEASES, VESICULOBULLOUS;

EID: 56149091491     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.09.015     Document Type: Article

References (15)

1. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 137 (2001) 765-770
2. Bigby M., Jick S., Jick H., and Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 256 (1986) 3358-3363
3. Roujeau J.C., and Stern R.S. Severe adverse cutaneous reactions to drugs. N Engl J Med 331 (1994) 1272-1285
4. Roujeau J.C. Clinical heterogeneity of drug hypersensitivity. Toxicology 209 (2005) 123-129
5. Wintroub B.U., and Stern R. Cutaneous drug reactions: pathogenesis and clinical classification. J Am Acad Dermatol 13 (1985) 167-179
6. Kaplan A.P. Drug-induced skin disease. J Allergy Clin Immunol 74 (1984) 573-579
7. Bronnimann M., and Yawalkar N. Histopathology of drug-induced exanthems: is there a role in diagnosis of drug allergy?. Curr Opin Allergy Clin Immunol 5 (2005) 317-321
8. Kauppinen K., and Stubb S. Drug eruptions: causative agents and clinical types. A series of inpatients during a 10-year period. Acta Derm Venereol 64 (1984) 320-324
9. Crowson A.N., Brown T.J., and Magro C.M. Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions. Am J Clin Dermatol 4 (2003) 407-428
10. Stubb S., Heikkila H., and Kauppinen K. Cutaneous reactions to drugs: a series of in-patients during a five year period. Acta Derm Venereol 74 (1994) 289-291
11. Fellner M.J., and Prutkin L. Morbilliform eruptions caused by penicillin. A study by electron microscopy and immunologic tests. J Invest Dermatol 55 (1970) 390-395
12. Weedon D. Skin pathology. 2nd ed. (2002), Churchill Livingstone, London
13. Crowson A.N., and Magro C.M. Recent advances in the pathology of cutaneous drug eruptions. Dermatol Clin 17 (1999) 537-559
14. In: Elder D., Elenitsas R., Jaworsky C., and Johnson B. (Eds). Lever's Histopathology of the skin. 8th ed. (1997), Raven Publishers, Philadelphia
15. Ackerman A.B. Histologic diagnosis of inflammatory skin diseases (1978), Lea & Febiger, Philadelphia